BioSpace News Archive

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced that the company scored Gold Level recognition in the American Heart Association (AHA) 2018 Workplace Health Achievement Index.

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) is pleased to announce that it has finalized the previously announced US$75 million credit facility with certain funds managed by JW Asset Management LLC, where Jason Wild, Chairman of the Board of TerrAscend, is the President and Chief Investment Officer.

Peli BioThermal, the global name in temperature controlled packaging, officially announced the appointment of Lynaye Reynolds as Worldwide Director of Quality for its BioThermal Division.

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) has included EndoPredict® in its recommendations for guiding adjuvant chemotherapy decisions for people with ER-positive, HER2-negative early breast cancer and who are lymph node-negative.

Pomerantz LLP is investigating claims on behalf of investors of Allergan plc

MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company will host the Michigan SAS Users Group (MSUG) for their first quarter meeting on Wednesday, March 13, 2019.

MilliporeSigma today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.

pMD, recently made enhancements to its free, secure messaging product.

New Face-to-Face Virtual Meeting Platform Answers Industry’s Need for Higher Engagement and Collaboration

Officials from Health Canada will hold a technical briefing to provide information on the Action Plan on Medical Devices.